DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer

A Clinical Proteomic Tumor Analysis Consortium (CPTAC) proteogenomic analysis prioritized dihydropyrimidinase-like-3 (DPYSL3) as a multilevel (RNA/protein/phosphoprotein) expression outlier specific to the claudin-low (CLOW) subset of triple-negative breast cancers. A PubMed informatics tool indicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsunuma, Ryoichi, Chan, Doug W., Kim, Beom-Jun, Singh, Purba, Han, Airi, Saltzman, Alexander B., Cheng, Chonghui, Lei, Jonathan T., Wang, Junkai, Roberto da Silva, Leonardo, Sahin, Ergun, Leng, Mei, Fan, Cheng, Perou, Charles M., Malovannaya, Anna, Ellis, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2018
Materias:
PNAS Plus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305012/
https://www.ncbi.nlm.nih.gov/pubmed/30498031
http://dx.doi.org/10.1073/pnas.1810598115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305012/
https://www.ncbi.nlm.nih.gov/pubmed/30498031
http://dx.doi.org/10.1073/pnas.1810598115

Ejemplares similares